Professor of Medicine, David Geffen School of Medicine at UCLA. Director, UCLA CARE Center
Oncology
Dr. Ronald T. Mitsuyasu, MD
|
|
Give Review
Ronald T. Mitsuyasu, MD is an expert in the field of Oncology. He graduated from David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA has a rank of 13 in research and a 7 in primary care He received awards:"America's Top Doctors", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California" and "Super Doctor". Ronald Mitsuyasu has written publications. He has 25 publications published with PubMed. The lastest publication is: 'Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: implications for the development of rectal microbicides for HIV prevention.' Ronald Mitsuyasu accepts Medicare payments and is registered with Medicare.gov.
Publications
- Stage-Stratified Approach to AIDS-Related Kaposi's Sarcoma: Implications for Resource-Limited Environments.
- Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: implications for the development of rectal microbicides for HIV prevention.
- High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
- A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AI...
- Efavirenz induces autophagy and aberrant differentiation in normal human keratinocytes.
- Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma.
- Curing HIV: lessons from cancer therapy.
- Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated human immunodeficiency virus infection.
- Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047.
- Pilot assessment of HIV gene therapy-hematopoietic stem cell clinical trial acceptability among minority patients and their advisors.
- Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.
- HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma.
- GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
- Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.
- Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes.
- Non--AIDS-defining malignancies in HIV.
- Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
- Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency vi...
- Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS.
- A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with ...
- A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
- Immune Reconstitution Strategies in HIV.
- Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy.
- High-Grade Anal Intraepithelial Neoplasia Among HIV-1-Infected Men Screening for a Multicenter Clinical Trial of a Human Papillomavirus Vaccine.
Schools
University of California At Los Angeles
Rush Presby St Lukes Hospital
UCLA Med Center
Doctors Specialties
- Internal Medicine
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- Super Doctor
Education
-
UCLA Medical Center -
Rush University Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1376562215 | |
| NPPES Provider LastName | MITSUYASU | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 90095 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 364.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1376562215 |
| Last Name Of The Provider | MITSUYASU |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
|
Dr. Meena R. Narayanan, MD |
|
Dr. Shamim V. Shakibai, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne M. Climaco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Boback Ziaeian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Myint Saw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dianne E. Quintana, MD |
|
|
Dr. Eric C. McGary, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara J. Gitlitz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jacek K. Pinski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James S. Hu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Syma Iqbal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick Soon-Shiong, MD |
|
|
Dr. Agustin A. Garcia, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Hamayun M. Nawaz, MD
This Doctor is OpenDoctor Recommended.
|